University of California San Francisco
Give to UCSF
Displaying 271 - 300 of 2966
-
-
Eczema and Asthma Share a Link. Can it Lead to New Treatments?
A collaboration is between two biomedical researchers bridges the laboratory and clinic to advance the science of itch, allergy and asthma.
-
Effects of Psychedelic Drugs Can Last for Days or Weeks, Research Finds
-
Do Combination Therapies Hold Hope for Prostate Cancer Patients?
A phase 1 trial shows promise in treating metastatic prostate cancer with a single priming dose of radioligand therapy and immunotherapy.
-
Breast Cancer Riddle: Best Ways to Screen and Treat
Laura Esserman discusses breast cancer risk factors, progress in the field and the importance of tailoring treatment for women with low-risk cancer while also identifying women at high risk of invasive cancer.
-
San Francisco’s Homeless Population 16 Times More Likely to Die Suddenly Than Housed Neighbors, Study Finds
-
Why Progress in Alzheimer’s Disease Treatment Has Taken 30 Years
UCSF's Adam Boxer, MD, PhD, and Harvard neurologist Reisa Sperling, MD, review the history of clinical trials over the past 30 years in Alzheimer’s research with what was learned and how new biomarkers and clinical trial approaches are being used to find more effective treatments in a more efficient way than in the past.
-
New Care Model Delivers Hepatitis C Treatment to Most Vulnerable
UCSF researchers developed a new neighborhood-based model of care that brings medicine to people immediately after being diagnosed with hepatitis C.
-
Homeless People Are 16 Times More Likely to Die Suddenly
A UCSF-led found that people who are experiencing homelessness have a 16-fold higher rate of sudden death from heart attacks, as well as other causes.
-
Advanced AI Chatbots Perpetuate Racist, Debunked Medical Ideas, Researchers Find
-
Does Suspending Kids from School Harm Their Grades and Health?
Being suspended from school or sent to the office is tied to a big drop in grade point average (GPA), especially for Black and Latinx children.
-
Breakthrough Drug Helps Children with New-Onset Type 1 Diabetes
A study found that children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab.
-
Neuroscientists to Reveal New Insights into Alzheimer's
UCSF experts to discuss amyloid therapies and dementia research at CTAD conference, addressing equity, novel treatments, and innovative studies.
-
Doubts Abound About a New Alzheimer’s Blood Test
-
COVID Cases Drop in California, but Experts Warn of a Winter Surge
-
Could the Neurons That Make You Scratch Be the Solution for Itch?
Scientists found that the nervous system tamps down allergic response, which could change how asthma, Crohn’s and other inflammatory diseases are treated.
-
$151M Grant Will Drive New Era in Alzheimer’s Treatments
A new study will combine an Alzheimer’s medication that slows disease progression in some patients with two other drugs to see if their effects can be amplified.
-
Are New Therapies on the Horizon for Painful Skin Condition?
UCSF's HS PROGRESS study aims to understand and treat Hidradenitis Suppurativa, an often debilitating condition disproportionately affecting women and people of color.
-
Breast Cancer Screening Guidelines Should Evolve With Science
-
Sandy Feng Elected to the National Academy of Medicine for 2023
UCSF transplant surgeon Sandy Feng, MD, PhD, has been elected to the National Academy of Medicine, one of the most prestigious organizations in health and medicine.
-
Feeling Terrible After Your Covid Shot? Then It’s Probably Working.
-
How Levels of ‘Good’ Cholesterol May Increase Dementia Risk
-
The Growing Case for Doing Less: How Harmless Cancers Are Being Overdiagnosed in America
-
Brief Dialysis May Be Best for Some Kidney Patients
Patients of acute kidney injury might not need as much dialysis as patients with end-stage kidney disease, and might benefit more from weaning off dialysis to avoid risk for heart disease, infection, organ damage and death.
-
Can a Simple Fentanyl Test Curb San Francisco’s Overdose Crisis?
With fentanyl overdose deaths at an all-time high, a successful UCSF-funded pilot project to distribute fentanyl test strips is being expanded by California Gov. Gavin Newsome as part of his plan to address the crisis.
-
UCSF Research Vital to First Drug for Deadly Bone Disease
FDA approves palovarotene (Sohonos) for rare FOP, reducing HO by 54%. Significant step in improving lives of affected patients.
-
Will a Pill Help New Moms Bounce Back from Postpartum Depression?
Zuranolone (Zurzuvae), the first pill for patients suffering from postpartum depression, is expected to be available by the end of 2023. Though it may relieve depressive symptoms, it has some drawbacks such as sedation and dangers in breastfeeding.
-
UCSF Gains Approval for New Research Building at Parnassus Heights
UCSF has been given the green light on a new research and academic building at Parnassus Heights, creating a vital collaborative space to drive innovations in scientific research and education.
-
Shared Mechanisms Allow SARS-CoV-2 Variants to Thrive Post-Vaccination
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.
-
150 Milestone: Robotic Procedure Changes Prostate Cancer Care
UCSF Health achieves 150 robotic focal HIFU procedures for prostate cancer, pioneering precision therapy with minimal side effects, prioritizing quality of life preservation.